Kathrin Jansen
PhD
Former Senior Vice President of Vaccine Research and Development
👥Biography 个人简介
Kathrin Jansen, renowned for leading the development of multiple breakthrough vaccines including the Pfizer-BioNTech COVID-19 vaccine, has contributed to the convergence of iPSC technology with vaccine and immunotherapy platforms. Her expertise in scaling biological product manufacturing has informed approaches to producing iPSC-derived cell therapy products at commercial scale. Her work on antigen presentation and immune activation has applications in engineering iPSC-derived antigen-presenting cells for cancer immunotherapy.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Kathrin Jansen 的研究动态
Follow Kathrin Jansen's research updates
留下邮箱，当我们发布与 Kathrin Jansen（Pfizer (Retired)）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment